Chien-Chung Chen

Chien-Chung Chen has worked in various roles in the biotechnology and medical fields since 1997. Starting as a Teaching Assistant at National Yang Ming University in Taiwan, Chen then became a Manager of Research Projects and Postdoctoral Researcher at the Perelman School of Medicine at the University of Pennsylvania from 2004 to 2011. From 2011 to 2015, Chen worked as a Senior Editor at Medjaden Bioscience Limited. After that, Chen worked as a Senior Research Scientist and Senior Scientist at WuXi AppTec from 2015 to 2018. From 2018 to 2019, Chen was an Associate Principal Scientist at WuXi Advanced Therapies. Currently, Chen is a Director and Associate Director of Analytical Development at Cabaletta Bio, where they are responsible for working internally with members of the CMC and R&D teams to identify analytical needs and resources, designing experiments, performing critical reviews of validation protocols and reports, and reviewing and interpreting analytical data.

Chien-Chung Chen completed their PhD in Pharmacology from Wayne State University School of Medicine between 1999 and 2004. Prior to that, they obtained an MS in Biochemstry from Chung Shan Medical University between 1993 and 1995.